These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

344 related articles for article (PubMed ID: 34073507)

  • 1. Therapeutics Targeting the Core Apoptotic Machinery.
    Hamilton C; Fox JP; Longley DB; Higgins CA
    Cancers (Basel); 2021 May; 13(11):. PubMed ID: 34073507
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibiting the inhibitors: Targeting anti-apoptotic proteins in cancer and therapy resistance.
    Shahar N; Larisch S
    Drug Resist Updat; 2020 Sep; 52():100712. PubMed ID: 32599435
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Targeting TRAIL in the treatment of cancer: new developments.
    Lim B; Allen JE; Prabhu VV; Talekar MK; Finnberg NK; El-Deiry WS
    Expert Opin Ther Targets; 2015; 19(9):1171-85. PubMed ID: 26004811
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Exploring the Mitochondrial Apoptotic Cell Death Landscape and Associated Components Serving as Molecular Targets, Primarily for Synthetic and Natural Drugs Targeting Oncology Therapeutics.
    Kaur I; Behl T; Sachdeva M; Bungau S; Venkatachalam T
    Curr Mol Pharmacol; 2021; 14(6):1066-1082. PubMed ID: 33494688
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cancer therapeutics: Targeting the apoptotic pathway.
    Khan KH; Blanco-Codesido M; Molife LR
    Crit Rev Oncol Hematol; 2014 Jun; 90(3):200-19. PubMed ID: 24507955
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Understanding Apoptosis and Apoptotic Pathways Targeted Cancer Therapeutics.
    Jan R; Chaudhry GE
    Adv Pharm Bull; 2019 Jun; 9(2):205-218. PubMed ID: 31380246
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Down-regulation of intracellular anti-apoptotic proteins, particularly c-FLIP by therapeutic agents; the novel view to overcome resistance to TRAIL.
    Hassanzadeh A; Farshdousti Hagh M; Alivand MR; Akbari AAM; Shams Asenjan K; Saraei R; Solali S
    J Cell Physiol; 2018 Oct; 233(10):6470-6485. PubMed ID: 29741767
    [TBL] [Abstract][Full Text] [Related]  

  • 8. FLIP as a therapeutic target in cancer.
    Humphreys L; Espona-Fiedler M; Longley DB
    FEBS J; 2018 Nov; 285(22):4104-4123. PubMed ID: 29806737
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mitocans: mitochondrial targeted anti-cancer drugs as improved therapies and related patent documents.
    Ralph SJ; Low P; Dong L; Lawen A; Neuzil J
    Recent Pat Anticancer Drug Discov; 2006 Nov; 1(3):327-46. PubMed ID: 18221044
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Voltage-Dependent Anion Channel 1 As an Emerging Drug Target for Novel Anti-Cancer Therapeutics.
    Shoshan-Barmatz V; Krelin Y; Shteinfer-Kuzmine A; Arif T
    Front Oncol; 2017; 7():154. PubMed ID: 28824871
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular targeting therapy of cancer: drug resistance, apoptosis and survival signal.
    Tsuruo T; Naito M; Tomida A; Fujita N; Mashima T; Sakamoto H; Haga N
    Cancer Sci; 2003 Jan; 94(1):15-21. PubMed ID: 12708468
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Targeting cell death signalling in cancer: minimising 'Collateral damage'.
    Fox JL; MacFarlane M
    Br J Cancer; 2016 Jun; 115(1):5-11. PubMed ID: 27140313
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Targeting Apoptosis in Cancer.
    Singh P; Lim B
    Curr Oncol Rep; 2022 Mar; 24(3):273-284. PubMed ID: 35113355
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Therapeutic targeting of death pathways in cancer: mechanisms for activating cell death in cancer cells.
    Tan TT; White E
    Adv Exp Med Biol; 2008; 615():81-104. PubMed ID: 18437892
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential effect of anti-apoptotic genes Bcl-xL and c-FLIP on sensitivity of MCF-7 breast cancer cells to paclitaxel and docetaxel.
    Wang Z; Goulet R; Stanton KJ; Sadaria M; Nakshatri H
    Anticancer Res; 2005; 25(3c):2367-79. PubMed ID: 16080463
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacological targeting of c-FLIP
    König C; Hillert-Richter LK; Ivanisenko NV; Ivanisenko VA; Lavrik IN
    Sci Rep; 2020 Nov; 10(1):20823. PubMed ID: 33257694
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of apoptosis repressor with a CARD domain (ARC) in the therapeutic resistance of renal cell carcinoma (RCC): the crucial role of ARC in the inhibition of extrinsic and intrinsic apoptotic signalling.
    Toth C; Funke S; Nitsche V; Liverts A; Zlachevska V; Gasis M; Wiek C; Hanenberg H; Mahotka C; Schirmacher P; Heikaus S
    Cell Commun Signal; 2017 May; 15(1):16. PubMed ID: 28464919
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Novel Apoptosis-Inducing Agents for the Treatment of Cancer, a New Arsenal in the Toolbox.
    Lim B; Greer Y; Lipkowitz S; Takebe N
    Cancers (Basel); 2019 Jul; 11(8):. PubMed ID: 31370269
    [No Abstract]   [Full Text] [Related]  

  • 19. Targeting the extrinsic apoptotic pathway in cancer: lessons learned and future directions.
    Ashkenazi A
    J Clin Invest; 2015 Feb; 125(2):487-9. PubMed ID: 25642709
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 18.